Date: Wednesday, July 19, 2023
Time: 2pm ET | 11am PT
Cost: Complimentary

Sponsored by: PHM

Consider these facts:

• Cancer may only affect 1 – 2% of the population, but it accounts for 10 – 15% of healthcare spend for many employers, making it the highest cost condition.
• The top 5% of an employer’s cancer cases typically account for 60% of cancer spend.
• The top two reimbursed stop-loss claim types are for cancers.
• Eleven of the top twenty high-cost injectable drugs are those that target cancer.

Rapid advancements in cancer bring new hope but often come with a steep price tag. Cancer costs continue to rise because of both an increase in cases and in spending on each case. Benefits leaders and their brokers need actionable insights to understand their employees’ cancer risk and develop a strategy to better manage cancer care.

Join the experts at PHM for this complimentary webcast to learn how to make more informed decisions to reduce cancer risk for employees, improve health outcomes and avoid unnecessary spend. You’ll learn:

• How early detection through advanced screenings can lead to better outcomes and lower treatment costs.
• How precision medicine, enabled by molecular diagnostics, allows for more targeted and effective treatments.  
• How to optimize specialty drug spend using science-backed information to identify effective cutting-edge therapies.
• And more…

REGISTER NOW!

Speakers:

Dr. Natalya Gertsik | Vice President, ClearCancer Solution Management | PHM
Tommy Axford, FSA, MAAA​​​​​​​ | Senior Vice President, Strategic Partnerships​​​​​​​ | PHM